Cite
Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling
MLA
Rijcken, Emile M., et al. “Immunoblockade of PSGL-1 Attenuates Established Experimental Murine Colitis by Reduction of Leukocyte Rolling.” The American Journal of Physiology, vol. 287, no. 1, July 2004, p. G115. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.119898294&authtype=sso&custid=ns315887.
APA
Rijcken, E. M., Laukoetter, M. G., Anthoni, C., Meier, S., Mennigen, R., Spiegel, H.-U., Bruewer, M., Senninger, N., Vestweber, D., & Krieglstein, C. F. (2004). Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling. The American Journal of Physiology, 287(1), G115.
Chicago
Rijcken, Emile M., Mike G. Laukoetter, Christoph Anthoni, Stephanie Meier, Rudolf Mennigen, Hans-Ullrich Spiegel, Matthias Bruewer, Norbert Senninger, Dietmar Vestweber, and Christian F. Krieglstein. 2004. “Immunoblockade of PSGL-1 Attenuates Established Experimental Murine Colitis by Reduction of Leukocyte Rolling.” The American Journal of Physiology 287 (1): G115. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.119898294&authtype=sso&custid=ns315887.